Elucidating the specific pharmacological mechanism of motion (MOA) of naturally taking place compounds may be challenging. Although Tarselli et al. (sixty) developed the very first de novo synthetic pathway to conolidine and showcased that this naturally taking place compound proficiently suppresses responses to both chemically induced and inflamma